Hannah Choe, MD
Ohio State University Comprehensive Cancer Center · Ohio State University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hannah Choe, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07249346 · Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationHannah Choe, MD · recruiting · Leukemia, Myelodysplasia, Chronic Myelomonocytic Leukemia · principal investigator
- Ph1/Ph2NCT04910152 · Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHDHannah Choe, MD · terminated · Acute Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease · principal investigator
- N/ANCT03719092 · High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell TransplantOhio State University Comprehensive Cancer Center · completed · Allogeneic Hematopoietic Stem Cell Transplantation Recipient · principal investigator
- N/ANCT01521039 · Assessment of MicroRNA Expression in Acute Graft-versus-Host DiseaseOhio State University Comprehensive Cancer Center · completed · Acute Graft-versus-Host Disease, Allogeneic Stem Cell Transplant · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHDR01CA252469 · NCI · OHIO STATE UNIVERSITY · PI Hannah Choe, Parvathi Ranganathan · fiscal years 2021 to 2025Named on NCT04910152
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.